DuPont hopes win on Swiss probiotic claim will help unlock EFSA process

DuPont hopes win on Swiss probiotic claim will help unlock EFSA process

DuPont has won official approval for probiotic-based gut health claims based on its strains in Switzerland after working with a local retailer.  The company hopes the latest victory will help unlock the process of approving probiotic health claims for Europe as a whole.

After last year approving a Danone gut health claim for Activia spoonable yogurt, Switzerland once again did what the rest of the European Union has not done, and approved a gut health claim.

DuPont, based in Wilmington, Delaware, proclaimed itself to be the first ingredients supplier to do so in Europe.

Fabienne Saadane-Oaks, vice president Health and Protection, DuPont Nutrition & Health said she hoped the Swiss decision would help inform the process of the evaluation of probiotic claims by the European Food Safety Authority (EFSA).

"Strictly speaking, this claim is just for Switzerland," Oaks told us. "Will it influence EFSA? I certainly hope so. Can I guarantee it? Certainly not. But we are in a very concentrated dialogue with EFSA about what they require in terms of science."

Leverage with EFSA?

Speaking at the Health Ingredients Europe trade show in Amsterdam in 2013, EFSA's health claims panel chair, professor Ambroise Martin, said a positive claim may be just around the corner.

“There is no problem to accept intermediate people [those that are stressed in some way but not technically sick or diseased] and with the developments in genomic science it is my feeling that we will soon positively assess a specific claim with a specific strain in a specific context, taking into an account a specific context and all the opinions that have gone before.”

“With this in mind someone could come with a basic dossier about transit time for instance. I have no doubt about this in the short to medium term. It could happen inside one or two years.”

Last year Swiss authorities found that the probiotic strain used in Activia, B. animalis CNCM-I_2494, gave a health benefit in healthy adults who consumed two portions of 125g a day.

The claim read: “Activia contributes to digestive comfort by reducing transit time and bloating.”

Related News

DuPont adds cholesterol-fighting probiotic in deal with Spanish company

DuPont adds cholesterol-fighting probiotic in deal with Spanish company

ISAPP: “The panel concluded that the general benefit of support­ing a healthy digestive tract was reinforced by evidence gathered on a large number of different probiotic strains representing commonly studied species.”

Time to recognise ‘core benefits of certain probiotics’: ISAPP

"The NDA Panel notes that new health relationships and outcome measures have been considered in the context of specific applications related to gut and immune function since April 2011.”

EFSA’s live culture: Help agency revise its gut and immune health claim guidance

Researchers say strong justification of the use of multiple strain evidence in health claim dossiers is needed to win EFSA over

How can reviews be used to get a probiotic health claim?

He clearly hasn't taken his L. casei...

Chr Hansen eyes first EFSA probiotic approval with uber-“pharma-style” immune study

'Our probiotic science will lead to an EFSA health claims approval': DuPont VP of marketing

'Our probiotic science will lead to an EFSA health claims approval': DuPont VP of marketing

Matching gene content to probiotic traits may offer fresh hope

The data jungle: Matching gene content to probiotic traits could offer industry fresh hope

New probiotics group aims to bridge regulator-industry communication GAPs

Danone launches new global probiotics group to “talk with lawmakers”

Related Products

See more related products